loader
Please Wait
Applying Filters...

Annual Sales of Odevixibat reported using PharmaCompass' compilation of Annual Reports of Global Pharmaceutical Companies.

Menu
Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 1Bylvay

PharmaCompass

01

Brand Name : Bylvay

Odevixibat

arrow
Luxepack
Not Confirmed

Brand Name : Bylvay

arrow
Luxepack
Not Confirmed

Odevixibat

Main Therapeutic Indication : Rare Diseases

Currency : USD

2023 Revenue in Millions : 80

2022 Revenue in Millions : 0

Growth (%) : Acquired from Albireo

blank